

National Aspergillosis Centre - INCAS trial
155 posts

@NACincas
INCAS is a Phase2 RCT (NCT05653193): adjunctive interferon gamma to treat chronic pulmonary aspergillosis Based at @MFT_NAC (@MFTnhs), funded by @NIHRresearch













Exciting #PhD opportunity to explore health effects of indoor mould at @OfficialUoM ! A hot topic that will likely gain importance. Will explore impact in several patient groups and use novel survey methods. @StephenJ_Fowler @MycologyRefManc @MFT_NAC findaphd.com/phds/project/h…








FungalDx24, a "very successful and groundbreaking event". Over 140 participants from 21 countries were able to enjoy the high-quality sessions, December 4-5 2024, Bethesda, MD, USA!




If you're an #NHS #respiratory doctor who manages patients with chronic #pulmonary #aspergillosis then please get in touch with @Ckosmidis (or inbox this account) to help us recruit for @NACincas 💉NCT05653193 - #NIHRfunded - Ph2 RCT ➡️More info: bit.ly/3UsYwjT



